UnitedHealth Group Incorporated (NYSE:UNH) Holdings Raised by Legacy Financial Advisors Inc.

Legacy Financial Advisors Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the second quarter, Holdings Channel.com reports. The fund owned 5,306 shares of the healthcare conglomerate’s stock after acquiring an additional 77 shares during the quarter. Legacy Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $2,702,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Signature Resources Capital Management LLC lifted its position in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. Saxony Capital Management LLC increased its position in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC increased its holdings in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares during the period. Fiduciary Group LLC raised its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after buying an additional 18 shares in the last quarter. Finally, Continuum Advisory LLC increased its stake in UnitedHealth Group by 0.6% in the second quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after acquiring an additional 19 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.4 %

UnitedHealth Group stock opened at $575.00 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average price of $577.10 and a 200-day moving average price of $520.47. The company has a market capitalization of $529.22 billion, a P/E ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.14 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on UNH shares. Morgan Stanley increased their target price on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Argus lifted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Monday, September 16th. Finally, HSBC lifted their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.